Practice Areas - Equity Capital Markets Law Firms and Lawyers
| Deal Date: | 15-06-2020 | Practice Area: | Equity Capital Markets |
| Deal Title: | ChemoCentryx Follow-On Offering of Common Stock | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Davis Polk advised the representatives of the several underwriters in connection with the SEC-registered offering of 5,980,000 shares of common stock of ChemoCentryx, Inc. (which included 780,000 shares pursuant to the full exercise of the underwriters? option to purchase additional shares), for total gross proceeds of approximately USD346.8 million. ChemoCentryx's common stock is listed on the Nasdaq Global Select Market under the symbol CCXI.
|
||
| Financial Center: | Silicon Valley | Value: | 100.01-500.00 |
| Advised Party: | Underwriter | Law Firm | Davis Polk |
| Issuer Jurisdiction - | United States | Listing Jurisdiction - | United States |
| Classification: |
Secondary Offerings and Placings NASDAQ: |
Lawyer | Alan F Denenberg |
